Verona Pharma plc / Estimates

    Fiscal Year Revenue Net income Net margin Free cash flow FCF margin
    (estimated) €1.89B +25.2% €1.05B +51.8% 55.5% +0.097 pp N/A N/A
    (estimated) €1.51B +41.4% €692.43M +24.2% 45.8% -0.063 pp N/A N/A
    (estimated) €1.07B +63.6% €557.48M +126.5% 52.2% +0.14 pp N/A N/A
    (estimated) €653.47M +81.8% €246.14M +1,615.7% 37.7% +0.34 pp €121.19M -9,149.7% 18.5% +0.19 pp
    (estimated) €359.54M +897.0% €14.35M -109.7% 4.0% +4.1 pp -€1.34M -98.7% -0.4% +2.9 pp
    €36.06M +∞% -€147.92M +219.0% -410.2% -4.1 pp -€104.23M +143.3% -289.0% -2.9 pp
    €0.00 -100.0% -€46.37M -20.9% N/A -€42.84M -16.1% N/A
    €390.65K -98.9% -€58.60M +23.6% -15,000.2% -150 pp -€51.03M +80.0% -13,064.0% -130 pp
    €34.12M +∞% -€47.40M -14.7% -138.9% -1.4 pp -€28.35M -26.1% -83.1% -0.83 pp
    €0.00 -100.0% -€55.57M +15.6% N/A -€38.38M -23.9% N/A
    €2.70K -15.5% -€48.06M +65.8% -1,781,367.5% -8.7K pp -€50.46M +94.2% -1,870,433.1% -11K pp
    €3.19K -99.8% -€28.98M -8.8% -907,384.6% -9.1K pp -€25.98M -18.2% -813,550.2% -8.1K pp
    €2.11M +∞% -€31.78M +347.4% -1,504.6% -15 pp -€31.76M +310.8% -1,503.3% -15 pp
    €0.00 +NaN% -€7.10M -43.6% N/A -€7.73M -26.8% N/A
    €0.00 +NaN% -€12.61M +155.9% N/A -€10.56M +78.0% N/A
    €0.00 +NaN% -€4.93M +3.1% N/A -€5.93M +61.0% N/A
    €0.00 +NaN% -€4.78M +2.4% N/A -€3.68M -18.9% N/A
    €0.00 +NaN% -€4.67M +52.3% N/A -€4.54M +65.0% N/A
    €0.00 +NaN% -€3.06M -8.6% N/A -€2.75M -3.5% N/A
    €0.00 +NaN% -€3.35M +13.0% N/A -€2.85M -3.6% N/A
    €0.00 +NaN% -€2.97M +28.8% N/A -€2.96M +32.6% N/A
    €0.00 +NaN% -€2.30M -16.8% N/A -€2.23M -17.5% N/A
    €0.00 +NaN% -€2.77M +102.6% N/A -€2.70M +257.9% N/A
    €0.00 +NaN% -€1.37M -2,762.6% N/A -€755.36K -19,228.7% N/A
    €0.00 €51.33K N/A €3.95K N/A

    Notifications